Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

London

Symbiosis in myzozoa: From Blood to Oysters to Corals

Infectious diseases continue to pose significant global health challenges, with HIV-1, Mycobacterium tuberculosis (Mtb), and the malaria parasite among the leading causes of death. Other [...]

Go to Top